Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, I'm going to discuss 2 cheap quality stocks to consider in this heated market.

2 extracted signals · 2 resolved · 0 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
16 Nov 2025, 18:57 UTC
Recorded by Tahlil Plus
18 May 2026, 20:23 UTC
Video preview for Friends! In this video, I'm going to discuss 2 cheap quality stocks to consider in this heated market.
Source overview

AI-generated source summary

The video presents a fundamental analysis of META and AMZN stocks, particularly focusing on META. It highlights that during market rallies, investors often overlook risks, while during sell-offs, they ignore opportunities. META is deemed inexpensive at 20 times earnings, compared to Google at 26, and Tesla at 197. It is over a trillion-dollar company still growing, with revenues up by 26% quarterly. Although the expectation is to go lower and if AI fears continue the stock may go to $550. The company has access to 3.5 billion users daily. For AMZN target is at $220. Both the robotics and the growing square footage is helping margins.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
2
Extracted from this source
Open
0
Still being tracked
Successful
1
Resolved successfully
Failed
1
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
50%
2 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    2 eligible signals linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.9
Tracked signals
355
Historical success
34.9%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail